Your browser doesn't support javascript.
loading
Survival after breast cancer according to participation in organised or opportunistic screening and deprivation.
Poiseuil, Marie; Payet, Catherine; Molinié, Florence; Dabakuyo-Yonli, Tienhan Sandrine; Mathoulin-Pelissier, Simone; Amadeo, Brice; Coureau, Gaëlle.
Affiliation
  • Poiseuil M; Univ. Bordeaux, Gironde General Cancer Registry, 33000 Bordeaux, France; Inserm, Bordeaux Population Health, Research Center U1219, Team EPICENE, 33000 Bordeaux, France. Electronic address: marie.poiseuil@u-bordeaux.fr.
  • Payet C; Centre Régional de Coordination du Dépistage des Cancers (CRCDC), Nouvelle Aquitaine, France. Electronic address: c.payet@depistagecancer-na.fr.
  • Molinié F; Loire-Atlantique/Vendée Cancer Registry, Nantes, France; CERPOP, Université de Toulouse, Toulouse, France; FRANCIM Network of French Cancer Registries, France. Electronic address: florence.molinie@chu-nantes.fr.
  • Dabakuyo-Yonli TS; FRANCIM Network of French Cancer Registries, France; Breast and Gynaecologic Cancer Registry of Côte d'Or, Georges Francois Leclerc Comprehensive Cancer Centre, INSERM U1231, 1 rue Professeur Marion, Dijon, France; Epidemiology and Quality of Life Research Unit, INSERM U1231, Dijon, France. Electron
  • Mathoulin-Pelissier S; Inserm, Bordeaux Population Health, Research Center U1219, Team EPICENE, 33000 Bordeaux, France; Institut Bergonie, Inserm CIC 1401, Clinical and Epidemiological Research Unit, 351 cours de la Libération, 33405 Talence cedex, France. Electronic address: simone.pelissier@u-bordeaux.fr.
  • Amadeo B; Univ. Bordeaux, Gironde General Cancer Registry, 33000 Bordeaux, France; Inserm, Bordeaux Population Health, Research Center U1219, Team EPICENE, 33000 Bordeaux, France; FRANCIM Network of French Cancer Registries, France. Electronic address: brice.amadeo@u-bordeaux.fr.
  • Coureau G; Univ. Bordeaux, Gironde General Cancer Registry, 33000 Bordeaux, France; Inserm, Bordeaux Population Health, Research Center U1219, Team EPICENE, 33000 Bordeaux, France; FRANCIM Network of French Cancer Registries, France. Electronic address: gaelle.coureau@u-bordeaux.fr.
Cancer Epidemiol ; 82: 102312, 2023 02.
Article de En | MEDLINE | ID: mdl-36508966
ABSTRACT

BACKGROUND:

Many studies have investigated the survival of women by comparing those who participated in organised screening with those who did not. However, among those who do not participate in organised screening, some women undergo opportunistic screening, but these women remain difficult to identify, particularly in France. Therefore, the aim of this study was to identify opportunistic screening, and then to study survival after breast cancer separately according to participation in organised, opportunistic or no screening, and taking into account sociodemographic inequalities.

METHODS:

The study population was identified from 3 French cancer registries, whose data was crossed with the screening coordination centers and the National Health Data System to identify the different type of screening. The European Deprivation Index was used to define the level of deprivation. We estimated net survival using the Pohar-Perme method.

RESULTS:

The 5-year net survival probabilities were higher for women who attended organised screening (97.0 %) than for women with opportunistic screening (94.1 %) or non-attenders (78.1 %). According to the level of deprivation, a significant difference was observed between the groups of women screened by organised and opportunistic screening, compared to the non-attenders.

CONCLUSION:

The identification of opportunistic screening is an important element in identifying women who do not screening. It enables to us to see that women who do not attend any screening have a much higher loss-of-opportunity in terms of survival than those who participate in organised or opportunistic screening, and even more so in the most deprived areas.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein Type d'étude: Diagnostic_studies / Prognostic_studies / Screening_studies Limites: Female / Humans Pays/Région comme sujet: Europa Langue: En Journal: Cancer Epidemiol Sujet du journal: EPIDEMIOLOGIA / NEOPLASIAS Année: 2023 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein Type d'étude: Diagnostic_studies / Prognostic_studies / Screening_studies Limites: Female / Humans Pays/Région comme sujet: Europa Langue: En Journal: Cancer Epidemiol Sujet du journal: EPIDEMIOLOGIA / NEOPLASIAS Année: 2023 Type de document: Article